Delivery Order SPE2DB20D6036-SPE2DB25FC8JX
- Not listed
- The Defense Logistics Agency awarded a $15,848.80 delivery order to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, with an ultimate completion date of September 24, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.40 on August 5, 2025, for the supply of Veklury 100 mg vials, an antiviral medication used in treating severe respiratory infections. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, valued at $7,924.40 under a firm fixed price contract type. This competitively awarded, non-set-aside delivery order has an ultimate completion date of September 16, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $15,848.80 and a firm fixed price contract structure. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $27,236.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VEKLURY 100 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- This delivery order, awarded August 25, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Veklury 100 mg vials with a ceiling value of $2,377.32. The contract utilizes firm fixed pricing with an ultimate completion date of September 16, 2025, and is classified as a child contract under a larger indefinite delivery vehicle. The award was made through open competition with no set-aside designation, and performance will occur at the vendor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $7,924.40. This firm fixed-price delivery order, which is a child contract under a larger vehicle, is scheduled for completion by September 11, 2025, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,618.40 firm-fixed-price contract is for the delivery of VEKLURY 100 MG vials and has a completion date of February 29, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of the COVID-19 treatment drug VEKLURY. The $13,606.80 contract has a completion date of January 11, 2024 and was awarded on December 19, 2023. As a prime contractor, Amerisourcebergen Drug Corp has an extensive history of supplying pharmaceuticals, medical supplies, and distribution services to DLA Troop...
- SPE2DB20D6036Indefinite Delivery Contract
- SPE2DB20D6036-SPE2DB25FC8JXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,886.30 to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, a critical antiviral medication. The contract is non-competitive, firm fixed-price delivery order with an ultimate completion date of September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply chain, serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As the prime contractor under the SPE2DX vehicle, AmerisourceBergen has demonstrated consistent capability to fulfill federal procurement requirements through competitive award processes and delivers medications across multiple therapeutic domains to support military healthcare operations globally. The Veklury supply under this delivery order supports ongoing medical readiness and treatment needs within the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 9/8/25 |